Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
A-Mark Precious Metals | AMRK | 1. avr 2025 | 25.24 | -0.51 |
a.k.a Brands | AKA | 1. avr 2025 | 15.18 | +12.61 |
A.O Smith | AOS | 1. avr 2025 | 65.60 | +0.37 |
A10 Networks | ATEN | 1. avr 2025 | 16.62 | +1.71 |
A2Z Cust2Mate Solutions | AZ | 1. avr 2025 | 6.91 | -2.12 |
AA Mission Acquisition | AAM | 1. avr 2025 | 10.27 | -1.53 |
AAA - A Rated Corporate Bond Ishares | QLTA | 1. avr 2025 | 47.51 | -0.04 |
Aadi Bioscience | AADI | 1. avr 2025 | 2.05 | 0.00 |
AAON | AAON | 1. avr 2025 | 79.16 | +1.32 |
AAR | AIR | 1. avr 2025 | 55.37 | -1.11 |
Aardvark Therapeutics | AARD | 1. avr 2025 | 8.29 | 0.00 |
Abacus Global Management | ABL | 1. avr 2025 | 7.33 | -2.14 |
Abbott Laboratories | ABT | 1. avr 2025 | 131.69 | -0.72 |
AbbVie | ABBV | 1. avr 2025 | 206.27 | -1.55 |
AbCellera Biologics | ABCL | 1. avr 2025 | 2.09 | -6.28 |
Abeona Therapeutics | ABEO | 1. avr 2025 | 4.45 | -6.51 |
Abercrombie & Fitch | ANF | 1. avr 2025 | 78.77 | +3.14 |
Aberdeen Asia-Pacificome Fund | FAX | 1. avr 2025 | 15.85 | +0.96 |
Aberdeen Australia Equity Fund | IAF | 1. avr 2025 | 4.05 | +0.50 |
Aberdeen Emerging Markets Fund | AEF | 1. avr 2025 | 4.96 | 0.00 |
Aberdeen Global Fund | FCO | 1. avr 2025 | 6.15 | +2.33 |
Aberdeen Global Infrastructure | ASGI | 1. avr 2025 | 18.43 | +0.22 |
Aberdeen Income Credit Strategies Fund | ACP | 1. avr 2025 | 5.87 | -0.34 |
Aberdeen Income Credit Strategies Pref | ACP-A | 1. avr 2025 | 21.50 | -0.14 |
Aberdeen Japan Equity Fund | JEQ | 1. avr 2025 | 6.44 | -0.95 |
Abits Group | ABTS | 1. avr 2025 | 2.69 | -10.63 |
Abivax SA - American Depositary Shares | ABVX | 1. avr 2025 | 5.89 | -5.76 |
Able View Global | ABLV | 1. avr 2025 | 0.82 | -8.33 |
ABM Industries | ABM | 1. avr 2025 | 47.89 | +1.12 |
Above Food Ingredients | ABVE | 1. avr 2025 | 0.57 | -4.39 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.